Healthcare provider profile · identity verified

Tyler Thomas Gray, MD

Family Practice · HOOD RIVER, OR · NPI 1699901363

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	150	48
Lisinopril	Lisinopril	147	41
Tamsulosin Hcl	Tamsulosin Hcl	115	32
Losartan Potassium	Losartan Potassium	108	32
Omeprazole	Omeprazole	103	33
Levothyroxine Sodium	Levothyroxine Sodium	100	25
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	93	21
Metoprolol Succinate	Metoprolol Succinate	89	24
Eliquis	Apixaban	85	20
Amlodipine Besylate	Amlodipine Besylate	83	31
Hydrochlorothiazide	Hydrochlorothiazide	81	23
Gabapentin	Gabapentin	71	20
Metformin Hcl Er	Metformin Hcl	60	22
Albuterol Sulfate Hfa	Albuterol Sulfate	54	16
Ozempic	Semaglutide	54	14
Furosemide	Furosemide	52	18
Tramadol Hcl	Tramadol Hcl	51	suppressed
Oxycodone Hcl	Oxycodone Hcl	50	suppressed
Metformin Hcl	Metformin Hcl	47	11
Trazodone Hcl	Trazodone Hcl	42	12
Prednisone	Prednisone	40	19
Duloxetine Hcl	Duloxetine Hcl	38	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Potassium Chloride	Potassium Chloride	38	suppressed
Simvastatin	Simvastatin	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	35	13
Escitalopram Oxalate	Escitalopram Oxalate	33	14
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	31	suppressed
Allopurinol	Allopurinol	30	suppressed
Lovastatin	Lovastatin	28	suppressed
Lorazepam	Lorazepam	27	suppressed
Pregabalin	Pregabalin	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	26	17
Acyclovir	Acyclovir	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	25	suppressed
Methadone Hcl	Methadone Hcl	25	suppressed
Spironolactone	Spironolactone	24	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	23	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Celecoxib	Celecoxib	20	suppressed
Clonazepam	Clonazepam	20	suppressed
Warfarin Sodium	Warfarin Sodium	20	suppressed
Baclofen	Baclofen	19	suppressed
Diazepam	Diazepam	19	suppressed
Olanzapine	Olanzapine	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Topiramate	Topiramate	18	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	17	17
Amiodarone Hcl	Amiodarone Hcl	17	suppressed
Finasteride	Finasteride	17	suppressed
Guanfacine Hcl	Guanfacine Hcl	17	suppressed
Ondansetron Odt	Ondansetron	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Nystatin	Nystatin	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Donepezil Hcl	Donepezil Hcl	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Azithromycin	Azithromycin	13	13
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	13	12
Bupropion Xl	Bupropion Hcl	12	suppressed
Ciclopirox	Ciclopirox	12	suppressed
Estradiol	Estradiol	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Jardiance	Empagliflozin	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Montelukast Sodium	Montelukast Sodium	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	12	suppressed
Testosterone	Testosterone	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	11	11
Diltiazem 24hr Er	Diltiazem Hcl	11	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	11	suppressed
Sertraline Hcl	Sertraline Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error